RNA vs TYRA

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 04, 2026

RNA

41.3
AI Score
VS
TYRA Wins

TYRA

44.8
AI Score

Investment Advisor Scores

RNA

41score
Recommendation
HOLD

TYRA

45score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric RNA TYRA Winner
Net Income -36.82M -84.86M RNA
Operating Income -39.90M -91.00M RNA
ROE -17.2% -24.0% RNA
ROA -13.1% -22.1% RNA
Total Assets 280.51M 383.36M TYRA
Cash 72.33M 73.83M TYRA
Current Ratio 8.73 14.91 TYRA
Free Cash Flow -37.20M -63.80M RNA

Relative Price Performance (Last 90 Days)

RNA 1M: -14.9% · 3M: -16.7% TYRA 1M: -12.9% · 3M: -13.8%

Current Technical Phase

RNA

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 31

RSI (14): 31.2 · Price: $10.36

TYRA

Markdown
Sell / avoid

Price below a falling SMA50 (slope -4.4%), weak momentum, RSI 37

RSI (14): 37.4 · Price: $22.03

Fundamentals Snapshot

Metric RNA TYRA
Market Cap
Forward P/E -1.3 -7.6
Trailing P/E
Revenue (TTM)
Revenue Growth -0.2% 0.0%
Gross Margin -0.6%
Operating Margin -7.5% 0.0%
EPS -5.36 -2.39
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, TYRA is currently the stronger investment candidate, winning 3 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.